Correction to "Effects of short-term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP-2ELM study" [0.03%]
对“托格列净短期治疗对2型糖尿病患者胰岛素分泌能力的影响：TOP-2ELM随机对照试验”的修正
Published Erratum
Journal of diabetes investigation. 2026 Jul 13. DOI:10.1111/jdi.70391 2026
Impact of system updates for sensor-augmented pump therapy on glycemic management in Japanese individuals with type 1 diabetes (SAP-J T1D study) [0.03%]
日本1型糖尿病患者的传感器增强泵治疗系统更新对血糖管理的影响（SAP-J T1D研究）
Shuichiro Saito,Akane Yamamoto,Yuya Miyazaki et al.
Shuichiro Saito et al.
Aims/introduction: Sensor-augmented pump (SAP) therapy has evolved sequentially, but long-term clinical evidence supporting these advances has remained limited. We here evaluated the impact of updates to SAP therapy on gl...
Lipid metabolism profiles as predictors of gestational diabetes mellitus risk: A retrospective study [0.03%]
脂质代谢谱作为预测妊娠期糖尿病风险的指标：一项回顾性研究
Xiaoyan Xiu,Huale Zhang,Yingying Lin et al.
Xiaoyan Xiu et al.
Objective: Gestational diabetes mellitus (GDM) is one of the most common metabolic disorders in pregnancy and is associated with significant maternal and fetal risks. The study aims to investigate lipid metabolism profile...
Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial [0.03%]
与饮食钾限制相比，锆环硅酸盐治疗2型糖尿病高血钾症的疗效和安全性：SILVERSTAR试验
Masahide Hamaguchi,Junya Hironaka,Hiroshi Okada et al.
Masahide Hamaguchi et al.
Aims/introduction: To demonstrate noninferiority of continued sodium zirconium cyclosilicate therapy versus a potassium-restricted diet in achieving normokalemia at Visit 7 (Days 28-42) in individuals with type 2 diabetes...
Clinical characteristics of Sarcopenic obesity in Japanese people with type 2 diabetes: A post hoc analysis of the sub-cohort iDIAMOND study [0.03%]
日本2型糖尿病患者 sarcopenic肥胖的临床特征：iDIAMOND子队列研究的事后分析
Hiroyasu Mori,Kasei Ko,Satoko Notomi et al.
Hiroyasu Mori et al.
Aims/introduction: Sarcopenic obesity, defined by reduced muscle mass and strength with excess adiposity, is poorly characterized in Japanese individuals with type 2 diabetes (T2D). This post hoc analysis assessed its pre...
Early diagnosis of gestational diabetes mellitus evidence from Asia countries: A meta-analysis and systematic review [0.03%]
亚洲国家关于妊娠期糖尿病早期诊断的证据：一项系统综述和meta分析
Ke Thi Lan Anh,Nguyen Ngoc Anh,Pham Minh Nguyet et al.
Ke Thi Lan Anh et al.
Introduction: Gestational diabetes mellitus (GDM) is a common metabolic complication of pregnancy associated with substantial maternal and neonatal morbidity. Asian populations demonstrate increased susceptibility to gluc...
Evaluation of inadvertent stigmatization of individuals with diabetes by healthcare professionals [0.03%]
医务人员无意中损害糖尿病患者的声誉的评估
Nagaaki Tanaka,Yoshiyuki Hamamoto,Kiyohiro Izumi et al.
Nagaaki Tanaka et al.
Aims/introduction: This study aimed to explore inadvertent stigmatizing attitudes of healthcare professionals (HCPs) toward people with diabetes (PWD) and to develop a questionnaire to assess such stigma. ...
Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice [0.03%]
利拉鲁肽与达格列净联合治疗可改善2型糖尿病小鼠的心肌病变和内皮功能障碍
An-Jun Tan,Tian-Rong Li,Jing-Jing Yang et al.
An-Jun Tan et al.
Background: Diabetic cardiomyopathy (DCM) and endothelial dysfunction are major drivers of cardiovascular morbidity in type 2 diabetes (T2DM). The present study investigates whether combined therapy with liraglutide (LIRA...
Association between cardiometabolic risk factors cluster and all-cause mortality in type 2 diabetes [0.03%]
2型糖尿病患者代谢危险因素谱与全因死亡率的关系分析
Qingfang He,Hongting Zhu,Yong Wang et al.
Qingfang He et al.
Objective: To investigate the association between the cardiometabolic risk factors cluster (CRFC) and all-cause mortality in type 2 diabetes (T2D). Method...